A Novel Class of Pyranocoumarin Anti-Androgen Receptor Signaling Compounds

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphorilated Polyprenols — A Novel Class of Compounds With Anti-Inflammatory and Bronchial Spasmolytic Activity

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2014English

Androgen Receptor Signaling in Salivary Gland Cancer

Cancers
Cancer ResearchOncology
2017English

FHL2, a Novel Tissue-Specific Coactivator of the Androgen Receptor

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2000English

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2011English

Novel Androgen Receptor Gene Variant Containing a Premature Termination Codon in a Patient With Androgen Insensitivity Syndrome

Journal of Pediatric and Adolescent Gynecology
Child HealthGynecologyPerinatologyObstetricsMedicinePediatrics
2019English

A Type I DnaJ Homolog, DjA1, Regulates Androgen Receptor Signaling and Spermatogenesis

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2005English

Dimeric Naphthoquinones, a Novel Class of Compounds With Prostate Cancer Cytotoxicity

BJU International
Urology
2010English

A Novel Androgen Receptor Mutation Resulting in Complete Androgen Insensitivity Syndrome and Bilateral Leydig Cell Hyperplasia

Journal of Andrology
2006English

miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SRC

Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy